| Executive Scientific Committee |
| Members |
| Prof. Y. BLERIOT (Université de Poitiers, Poitiers, France) |
| Dr R. H. DODD (ICSN CNRS, Gif-Sur-Yvette, France) |
| Dr P. GEORGE (SCT & Independent Scientific Expert & Adviser, Longvilliers, France) |
| Prof. J.-P. GESSON (Université de Poitiers, Poitiers, France) |
| Dr F. LEFOULON (Servier Laboratories, Orléans, France) |
| Prof. S. PAPOT (University of Poitiers, Poitiers, France) |
| Dr F. SCHMIDT (Institut Curie, Paris, France) |
| Scientific Advisory Board |
| Members |
| Prof. K. AUGUSTYNS (University of Antwerp, Antwerp, Belgium) |
| Dr V. BARBEROUSSE (Abbott - Laboratoire Fournier, France) |
| Dr H. BOETTCHER (Merck Serono, Darmstadt, Germany) |
| Prof. G. CRUCIANI (University of Perugia, Perugia, Italy) |
| Prof. G. DELERIS (University Bordeaux Segalen, Bordeaux, France) |
| Dr B. DEPREZ (Université of Lille, Lille, France) |
| Prof. P. DUMY (Ecole Nationale Supérieure de Chimie de Montpellier (ENSCM), Montpellier, France) |
| Dr J. FERNANDEZ (Janssen R&D, Toledo, Spain) |
| Dr G. GUICHARD (The European Institute of Chemistry and Biology (IECB), Pessac, France) |
| Dr L. HENNEQUIN (AstraZeneca, Reims, France) |
| Dr S. JEGHAM (Sanofi, MONTPELLIER, France) |
| Prof. F. KOZIELSKI (Beatson Institute for Cancer Research, Glasgow, United Kingdom) |
| Dr M. LANG (Novartis Pharma, Basel, Switzerland) |
| Dr O. LAVERGNE (., Les Ulis, France) |
| Prof. J. MITTENDORF (Bayer Schering Pharma, Wuppertal, Germany) |
| Dr P. MOHR (F. Hoffmann-La Roche, Basel, Switzerland) |
| Prof. D. NERI (ETH Zürich, Zürich, Switzerland) |
| Dr D. OBRECHT (Polyphor, Allschwil, Switzerland) |
| Dr M. PEREZ (Pierre Fabre, Toulouse, France) |
| Prof. H. U. STILZ (Sanofi & EMFC, Malov, Denmark) |
| Dr B. VIDAL (Almirall, Barcelona, Spain) |
| Dr A. WAGNER (Université de Strasbourg, Illkirch, France) |
